Serum TRAIL Levels Increase Shortly After Insulin Therapy and Metabolic Stabilization in Children with Type 1 Diabetes Mellitus

Overview

Journal Acta Diabetol

Specialty Endocrinology

Date 2015 Apr 13

PMID 25863780

Citations 6

Authors

Gianluca Tornese

Veronica Tisato

Lorenzo Monasta

Liza Vecchi Brumatti

Giorgio Zauli

Paola Secchiero

Affiliations

Soon will be listed here.

Citing Articles

Immunomodulatory Functions of TNF-Related Apoptosis-Inducing Ligand in Type 1 Diabetes.

Fogarasi M, Dima S Cells. 2024; 13(20.

PMID: 39451194 PMC: 11506310. DOI: 10.3390/cells13201676.

Expression-based Genome-wide Association Study Links OPN and IL1-RA With Newly Diagnosed Type 1 Diabetes in Children.

Jia X, Toda K, He L, Miao D, Yamada S, Yu L J Clin Endocrinol Metab. 2022; 107(7):1825-1832.

PMID: 35460250 PMC: 9391606. DOI: 10.1210/clinem/dgac256.

Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence.

Koliaki C, Katsilambros N Int J Mol Sci. 2022; 23(6).

PMID: 35328646 PMC: 8949963. DOI: 10.3390/ijms23063225.

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?.

Bernardi S, Voltan R, Rimondi E, Melloni E, Milani D, Cervellati C Clin Sci (Lond). 2019; 133(10):1145-1166.

PMID: 31097613 PMC: 6526163. DOI: 10.1042/CS20181116.

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease.

Arcidiacono M, Rimondi E, Maietti E, Melloni E, Tisato V, Gallo S PLoS One. 2018; 13(9):e0203716.

PMID: 30204795 PMC: 6133360. DOI: 10.1371/journal.pone.0203716.

References

Zauli G, Toffoli B, di Iasio M, Celeghini C, Fabris B, Secchiero P . Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes. Diabetes. 2010; 59(5):1261-5. PMC: 2857907. DOI: 10.2337/db09-1771. View

Di Bartolo B, Chan J, Bennett M, Cartland S, Bao S, Tuch B . TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice. Diabetologia. 2011; 54(12):3157-67. DOI: 10.1007/s00125-011-2308-0. View

Tornese G, Iafusco D, Monasta L, Agnoletto C, Tisato V, Ventura A . The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement. Acta Diabetol. 2013; 51(2):239-46. DOI: 10.1007/s00592-013-0507-5. View

Secchiero P, Rimondi E, di Iasio M, Agnoletto C, Melloni E, Volpi I . C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. Clin Cancer Res. 2013; 19(8):1949-59. DOI: 10.1158/1078-0432.CCR-12-3027. View

Karavanaki K, Kakleas K, Georga S, Bartzeliotou A, Mavropoulos G, Tsouvalas M . Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis. Clin Biochem. 2012; 45(16-17):1383-8. DOI: 10.1016/j.clinbiochem.2012.05.003. View